Pathogenic variants in STUB1 were initially described in autosomal recessive spinocerebellar ataxia type 16 and dominant cerebellar ataxia with cerebellar cognitive dysfunction (SCA48).
We analyzed a large series of 440 index cerebellar ataxia cases, mostly with dominant inheritance.
STUB1 variants were detected in 50 patients. Age at onset and severity were remarkably variable. Cognitive impairment, predominantly frontal syndrome, was observed in 54% of STUB1 variant carriers, including five families with Huntington or frontotemporal dementia disease–like phenotypes associated with ataxia, while no STUB1 variant was found in 115 patients with frontotemporal dementia. We report neuropathological findings of a STUB1 heterozygous patient, showing massive loss of Purkinje cells in the vermis and major loss in the cerebellar hemispheres without atrophy of the pons, hippocampus, or cerebral cortex. This screening of STUB1 variants revealed new features: (1) the majority of patients were women (70%) and (2) “second hits” in AFG3L2, PRKCG, and TBP were detected in three families suggesting synergic effects.
Our results reveal an unexpectedly frequent (7%) implication of STUB1 among dominantly inherited cerebellar ataxias, and suggest that the penetrance of STUB1 variants could be modulated by other factors, including sex and variants in other ataxia-related genes.
Subscribe to Journal
Get full journal access for 1 year
only $94.83 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Anonymized data from this study will be shared by request from any qualified investigator.
Shi Y, Wang J, Li J-D, et al. Identification of CHIP as a novel causative gene for autosomal recessive cerebellar ataxia. PLoS One. 2013;8:e81884.
Shi C-H, Schisler JC, Rubel CE, et al. Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet. 2014;23:1013–1024.
Gazulla J, Izquierdo-Alvarez S, Sierra-Martínez E, Marta-Moreno ME, Alvarez S. Inaugural cognitive decline, late disease onset and novel STUB1 variants in SCAR16. Neurol Sci. 2018;39:2231–2233.
Genis D, Ortega-Cubero S, San Nicolás H, et al. Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48). Neurology. 2018;91:e1988.
Schmahmann JD. The cerebellum and cognition. Neurosci Lett. 2019;688:62–75.
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt 4):561–579.
De Michele G, Lieto M, Galatolo D, et al. Spinocerebellar ataxia 48 presenting with ataxia associated with cognitive, psychiatric, and extrapyramidal features: a report of two Italian families. Parkinsonism Relat Disord. 2019;65:91–96.
Lieto M, Riso V, Galatolo D, et al. The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families. Eur J Neurol. 2020;27:498–505.
Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–1014.
Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456–2477.
Mariani L-L, Tesson C, Charles P, et al. Expanding the spectrum of genes Involved in Huntington disease using a combined clinical and genetic approach. JAMA Neurol. 2016;73:1105–1114.
Coutelier M, Coarelli G, Monin M-L, et al. A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. Brain. 2017;140:1579–1594.
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–315.
Bettencourt C, de Yébenes JG, López-Sendón JL, et al. Clinical and neuropathological features of spastic ataxia in a Spanish family with novel compound heterozygous mutations in STUB1. Cerebellum. 2015;14:378–381.
Hayer SN, Deconinck T, Bender B, et al. STUB1/CHIP mutations cause Gordon Holmes syndrome as part of a widespread multisystemic neurodegeneration: evidence from four novel mutations. Orphanet J Rare Dis. 2017;12:31.
Heimdal K, Sanchez-Guixé M, Aukrust I, et al. STUB1 mutations in autosomal recessive ataxias—evidence for mutation-specific clinical heterogeneity. Orphanet J Rare Dis. 2014;9:146.
Synofzik M, Schüle R, Schulze M, et al. Phenotype and frequency of STUB1 mutations: next-generation screenings in Caucasian ataxia and spastic paraplegia cohorts. Orphanet J Rare Dis. 2014;9:57.
Gostout B, Liu Q, Sommer SS. “Cryptic” repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. Am J Hum Genet. 1993;52:1182–1190.
Fujigasaki H, Martin JJ, De Deyn PP, et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain. 2001;124(Pt 10):1939–1947.
Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of Huntington’s disease onset. Cell. 2019;178:887–900.e14.
Madrigal SC, McNeil Z, Sanchez-Hodge R, et al. Changes in protein function underlie the disease spectrum in patients with CHIP mutations. J Biol Chem. 2019;294:19236–19245.
Coutelier M, Burglen L, Mundwiller E, et al. GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia. Neurology. 2015;84:1751–1759.
Klebe S, Depienne C, Gerber S, et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain. 2012;135(Pt 10):2980–2993.
Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9:885–894.
Hoche F, Guell X, Sherman JC, Vangel MG, Schmahmann JD. Cerebellar contribution to social cognition. Cerebellum. 2016;15:732–743.
Sayah S, Rotgé J-Y, Francisque H, et al. Personality and neuropsychological profiles in Friedreich ataxia. Cerebellum. 2018;17:204–212.
Chen D-H, Latimer C, Yagi M, et al. Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization. Neurol Genet. 2020;6:1–13.
We are very grateful to the patients and their families for participating. Many thanks to Ludivine Chamard, Pierre Clavelou, Nathalie Daluzeau, Didier Deffond, Bernard Floccard, Pascal Labouret, Isabelle Le Ber, Roberto Marconi, Pascal Menage, Michel Obadia, Elisabeth Ollagnon Roman, Anne-Marie Ouvrard-Hernandez, Michel Rendu, Vincent de la Sayette, Xavier Soulages, Philippe Svrin, Maya Tchikvildazé, Jacques Touchon, Urielle Ullmann, Fausto Viader, Francois Viallet, and Marc Wagner, who referred cases. Many thanks to the Pitié-Salpêtrière Brain and DNA and cell banks. Members of the SPATAX network are listed in Supplementary data. Funding provided by Grand Prix Lamonica de Neurologie (Académie des Sciences).
The authors declare no conflicts of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Roux, T., Barbier, M., Papin, M. et al. Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment. Genet Med (2020). https://doi.org/10.1038/s41436-020-0899-x
- spinocerebellar ataxia
- cognitive impairment